Posted in Regulatory FDA Approves Extended Dosing Interval for Regeneron’s EYLEA HD (aflibercept) April 15, 2026 Big Molecule Watch On April 2, 2026, Regeneron Pharmaceuticals announced that the U.S. RegulatoryOphthalmologyRead full story